RBC Capital Markets kept its outperform rating and 350p price target on Barratt Redrow PLC, arguing the recent share price drop was overdone and not reflective of housing market data. The bank highlighted the potential revival of the Help-to-Buy scheme as a positive catalyst for the company. Barratt Redrow recently reported full-year results and is undergoing leadership changes with a new CEO starting September 21. Despite market challenges and integration issues from its 2024 Redrow acquisition, the company aims to increase home sales to 22,000 annually in the medium term.
Barratt Redrow and its recent developments are presented here with Pluang's Consumer Cyclical sector market data as of Sep 17, 2026 23:41 WIB. For readers following Consumer Cyclical stocks, 70 of 105 priced US stocks rose while 35 fell today. Notable movers include Quantumscape Corp (QS) at USD 5.30 with a 1-day change of +6.00%, Victoria's Secret & Co (VSXY) at USD 78.28 up +5.84%, and Rivian Automotive, Inc. (RIVN) at USD 15.84 with a +4.01% gain. The most notable figure is the 97% sell order activity on Quantumscape Corp.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
